Evidence map›Paper›PMID 35025877›Full record

ArticlePloS one2022

A short plus long-amplicon based sequencing approach improves genomic coverage and variant detection in the SARS-CoV-2 genome.

Carlos Arana, Chaoying Liang, Matthew Brock, Bo Zhang, Jinchun Zhou, Li Chen, Brandi Cantarel, Jeffrey SoRelle, Lora V Hooper, Prithvi Raj

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Carlos AranaDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, TX, United States of America.
Chaoying LiangDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, TX, United States of America.
Matthew BrockDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, TX, United States of America.
Bo ZhangDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, TX, United States of America.
Jinchun ZhouDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, TX, United States of America.
Li ChenDepartment of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, United States of America.
Brandi CantarelDepartment of Bioinformatics, University of Texas Southwestern Medical Center, Dallas, TX, United States of America.
Jeffrey SoRelleDepartment of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, United States of America.
Lora V HooperDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, TX, United States of America.
Prithvi RajDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, TX, United States of America.ORCID 0000-0003-4068-4358
The University of Texas Southwestern Medical Center · USHoward Hughes Medical Institute · US

Funding

Microbial Regulation of Retinol Transport and its Role in Intestinal ImmunityR01DK070855 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI LORA V HOOPER · 2005 to 2026
$7.9M
NIDDK NIH HHS R01 DK070855
6 · The paper itself

Abstract

High viral transmission in the COVID-19 pandemic has enabled SARS-CoV-2 to acquire new mutations that may impact genome sequencing methods. The ARTIC.v3 primer pool that amplifies short amplicons in a multiplex-PCR reaction is one of the most widely used methods for sequencing the SARS-CoV-2 genome. We observed that some genomic intervals are poorly captured with ARTIC primers. To improve the genomic coverage and variant detection across these intervals, we designed long amplicon primers and evaluated the performance of a short (ARTIC) plus long amplicon (MRL) sequencing approach. Sequencing assays were optimized on VR-1986D-ATCC RNA followed by sequencing of nasopharyngeal swab specimens from fifteen COVID-19 positive patients. ARTIC data covered 94.47% of the virus genome fraction in the positive control and patient samples. Variant analysis in the ARTIC data detected 217 mutations, including 209 single nucleotide variants (SNVs) and eight insertions & deletions. On the other hand, long-amplicon data detected 156 mutations, of which 80% were concordant with ARTIC data. Combined analysis of ARTIC + MRL data improved the genomic coverage to 97.03% and identified 214 high confidence mutations. The combined final set of 214 mutations included 203 SNVs, 8 deletions and 3 insertions. Analysis showed 26 SARS-CoV-2 lineage defining mutations including 4 known variants of concern K417N, E484K, N501Y, P618H in spike gene. Hybrid analysis identified 7 nonsynonymous and 5 synonymous mutations across the genome that were either ambiguous or not called in ARTIC data. For example, G172V mutation in the ORF3a protein and A2A mutation in Membrane protein were missed by the ARTIC assay. Thus, we show that while the short amplicon (ARTIC) assay provides good genomic coverage with high throughput, complementation of poorly captured intervals with long amplicon data can significantly improve SARS-CoV-2 genomic coverage and variant detection.

Indexed as

COVID-19Genome, ViralGenomicsHumansRNA, ViralSARS-CoV-2Sequence AnalysisWhole Genome SequencingRNA, Viral

Identifiers

PMID35025877
PMCPMC8757904
OpenAlexW4225823765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.